Published in Healthcare Mergers, Acquisitions and Ventures Week, March 24th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Emergent BioSolutions.
Report 1: Emergent BioSolutions Inc. (EBS), a leader in biodefense medical countermeasures, applauded Congress and President Bush as he signed into law the Pandemic and All-Hazards Preparedness Act, which authorizes appropriations through 2011 to improve bioterrorism and other public health emergency planning and preparedness activities and creates the Biomedical Advanced Research and Development Authority, or BARDA, under the direction of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week